Estimation of cardiac output in a pharmacological trial using a simple method based on arterial blood pressure signal waveform: a comparison with pulmonary thermodilution and echocardiographic methods Jani PenttiläAmir SnapirTom Kuusela Clinical Trials 29 March 2006 Pages: 401 - 407
Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish population Marja K. PasanenJanne T. BackmanMikko Niemi Pharmacogenetics 21 April 2006 Pages: 409 - 415
CYP3A phenotypes and genotypes in North Indians Naushad RaisYogesh K. ChawlaKrishan K. Kohli Pharmacogenetics 21 April 2006 Pages: 417 - 422
CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis Nicolas VuilleumierMichel F. RossierDenis Hochstrasser Pharmacogenetics 27 April 2006 Pages: 423 - 429
Effects of fluvastatin and cigarette smoking on CYP2C9 activity measured using the probe S-warfarin Myong-Jin KimAnne N. NafzigerJoseph S. Bertino Jr Pharmacogenetics 27 April 2006 Pages: 431 - 436
The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers Lene Noehr-JensenPer DamkierKim Brosen Pharmacokinetics and Disposition 28 April 2006 Pages: 437 - 445
Tolcapone decreases plasma levels of S-adenosyl-L-homocysteine and homocysteine in treated Parkinson’s disease patients Thomas MüllerWilfried Kuhn Pharmacikinetics and Disposition 22 April 2006 Pages: 447 - 450
Rifampicin is only a weak inducer of CYP1A2-mediated presystemic and systemic metabolism: studies with tizanidine and caffeine Janne T. BackmanMarika T. GranforsPertti J. Neuvonen Pharmacokinetics and Disposition 27 April 2006 Pages: 451 - 461
Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamide Mikko NiemiAleksi TornioJanne T. Backman Pharmacokinetics and Disposition 27 April 2006 Pages: 463 - 472
Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors? David W. J. ClarkJohanna Strandell Pharmacoepidemiology and Prescription 22 April 2006 Pages: 473 - 479
Characterization of the novel CYP2A6*21 allele using in vivo nicotine kinetics Nael Al KoudsiJill C. MwenifumboRachel F. Tyndale Short Communication 28 April 2006 Pages: 481 - 484
Antioxidant effects of simvastatin in primary and secondary prevention of coronary heart disease A. TavridouA. EfthimiadisH. Paschalidou Short Communication 21 April 2006 Pages: 485 - 489
Possible fluconazole–fentanyl interaction—a case report Pär HallbergLeif MarténMia Wadelius Letter to the Editors 21 April 2006 Pages: 491 - 492